Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non–small-cell Lung Cancer Brain Metastases
- 10 November 2020
- journal article
- research article
- Published by Elsevier BV in Clinical Lung Cancer
- Vol. 22 (2), 110-119
- https://doi.org/10.1016/j.cllc.2020.10.014
Abstract
No abstract availableKeywords
Funding Information
- Herman and Gwendolyn Shapiro Foundation
This publication has 44 references indexed in Scilit:
- Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgeryCancer, 2016
- Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastasesOncoImmunology, 2015
- Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor AntigenCancer Immunology Research, 2015
- Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgeryJournal of Neurosurgery, 2013
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial GliomasEndocrine, 2013
- Neuropsychological testing and biomarkers in the management of brain metastasesRadiation Oncology, 2008
- The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan HorsesClinical Cancer Research, 2007
- Treatment of brain metastases from lung cancer: chemotherapyLung Cancer, 2004
- Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance SystemJournal of Clinical Oncology, 2004
- Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05Endocrine, 2000